Carboxypeptidase M modulates BMSCs osteogenesis–adipogenesis via the MAPK / ERK pathway: An integrated single‐cell and bulk transcriptomic study
- 7 May 2024
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 38 (9) , e23657
Abstract
The pathogenesis of osteoporosis (OP) is closely associated with the disrupted balance between osteogenesis and adipogenesis in bone marrow‐derived mesenchymal stem cells (BMSCs). We analyzed published single‐cell RNA sequencing (scRNA‐seq) data to dissect the transcriptomic profiles of bone marrow‐derived cells in OP, reviewing 56 377 cells across eight scRNA‐seq datasets from femoral heads (osteoporosis or osteopenia n = 5, osteoarthritis n = 3). Seventeen genes, including carboxypeptidase M (CPM), were identified as key osteogenesis‐adipogenesis regulators through comprehensive gene set enrichment, differential expression, regulon activity, and pseudotime analyses. In vitro, CPM knockdown reduced osteogenesis and promoted adipogenesis in BMSCs, while adenovirus‐mediated CPM overexpression had the reverse effects. In vivo, intraosseous injection of CPM ‐overexpressing BMSCs mitigated bone loss in ovariectomized mice. Integrated scRNA‐seq and bulk RNA sequencing analyses provided insight into the MAPK/ERK pathway's role in the CPM ‐mediated regulation of BMSC osteogenesis and adipogenesis; specifically, CPM overexpression enhanced MAPK/ERK signaling and osteogenesis. In contrast, the ERK1/2 inhibitor binimetinib negated the effects of CPM overexpression. Overall, our findings identify CPM as a pivotal regulator of BMSC differentiation, which provides new clues for the mechanistic study of OP.Keywords
Funding Information
- National Key Research and Development Program of China (2018HB001)
- National Natural Science Foundation of China (82370886)
This publication has 49 references indexed in Scilit:
- Long noncoding RNA repressor of adipogenesis negatively regulates the adipogenic differentiation of mesenchymal stem cells through the hnRNP A1‐PTX3‐ERK axisClinical and Translational Medicine, 2020
- Interactions between carboxypeptidase M and kinin B1 receptor in endothelial cellsInflammation Research, 2019
- Binimetinib, a novel MEK1/2 inhibitor, exerts anti-leukemic effects under inactive status of PI3Kinase/Akt pathwayInternational Journal of Hematology, 2019
- Establishing Criteria for Human Mesenchymal Stem Cell PotencyStem Cells, 2015
- Bradykinin Regulates Osteoblast Differentiation by Akt/ERK/NFκB Signaling AxisJournal of Cellular Physiology, 2014
- Osteoclast-Derived Complement Component 3a Stimulates Osteoblast DifferentiationJournal of Bone and Mineral Research, 2014
- 1α,25(OH)2-vitamin D3 stimulates rapid plasma membrane calcium influx via MAPK activation in immature rat Sertoli cellsBiochimie, 2012
- Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL‐1βJournal of Cellular Biochemistry, 2011
- Fifth complement cascade protein (C5) cleavage fragments disrupt the SDF-1/CXCR4 axis: Further evidence that innate immunity orchestrates the mobilization of hematopoietic stem/progenitor cellsExperimental Hematology, 2010
- Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: Cross talk with the osteoblastogenic programCellular and Molecular Life Sciences, 2008